Compare Dialectica srl vs Exelixis
Customers evaluate the quality of Dialectica srl's products using the following success metrics.
Overview
Dialectica srl is based in Italy
Dialectica offers Neural Stem Cell-based Systems and Assays for drug screening in neurodegenerative diseases. The mission of Dialectica is to add value to the link between research and pharmaceutical and biotechnology companies that are active in the discovery of therapeutics for brain diseases. Dialectica develops and optimize Neural Stem Cell-based Systems and Assays for drug screening in neurodegenerative diseases.
Exelixis is 30 yrs old and is based in United States.
Exelixis (NASDAQ: EXEL) is a development-stage biotechnology company dedicated to the discovery and development of small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer.
Demo Video
Leadership
Dorotea Rigamonti (Chief Executive Officer)
Stelios B. Papadopoulos (Founder)
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Dialectica srl has not claimed their profile.
Work for Dialectica srl? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Dialectica srl?
Claim your profile now.
Information not available because Exelixis has not claimed their profile.
Work for Exelixis? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Exelixis?
Claim your profile now.